European Agency Recommends Two New Adalimumab Biosimilars European Agency Recommends Two New Adalimumab Biosimilars

The Committee for Medicinal Products for Human Use gave a positive opinion for the approval of Hukyndra and Libmyris, each of which will have 15 indications.International Approvals

Source: Medscape Medical News Headlines - September 17, 2021 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news